research
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Good Risk Acute Myelocytic Leukemia (AML) Carrying T(8:21) or INV(16)
- Publication date
- 28 February 2009
- Publisher
- American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.